Delivery Order SPE2DB22D2005-SPE2DB25FJQF4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100, valued at $1,242.74. This is a firm fixed price delivery order with an ultimate completion date of July 23, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,389.74 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 20 mg capsules (100-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of July 24, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $10,468.50 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 25 mg capsules (100-count units). This firm fixed price, non-set-aside delivery order was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg tablets (100-count) valued at $1,000.16, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count) with a ceiling value of $2,446.15. This firm fixed-price delivery order, which is not set-aside, represents a routine pharmaceutical procurement under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The order will be fulfilled...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,144.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 29, 2025. The delivery order was issued on July 28, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100s, with a ceiling value of $4,627.63 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.60, is for the delivery of 4,568,135,213 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a performance period through May 6, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQF4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $2,030.22. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting portfolio demonstrates extensive experience fulfilling competitive awards for diverse pharmaceutical commodities across multiple therapeutic domains, including specialty medications, generic drugs, and medical supplies. The DLA Troop Support Medical IDC enables AmerisourceBergen to deliver medications and supplies globally to support military healthcare needs, positioning the company as a key vendor within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/22/25 |